Tradestie Institutional Equity Comparison Engine

AQST vs TLPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AQST Overall Edge

AQST Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aquestive Therapeutics, Inc. Common Stock (AQST) driven by superior Growth & Margin, Momentum & Technical while TLPH counters with relative strength in Valuation, Options & Structure. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus TLPH at 1.0x Forward P/E and -1474700.0% operating margin (+0.0% YoY). In options structure, AQST sits in BREAKDOWN (40th %ile IV; Dealer Gamma Walls on Pro) against TLPH sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TLPH
AQST N/M vs TLPH 1.0x Fwd P/E
Growth & Margin Winner AQST
Op Margin -114.1% vs -1474700.0% ยท YoY -41.0% vs +0.0%
Momentum & Technical Winner AQST
1Y -28.8% vs -18.0% ยท 52W Pos 22% vs 20%
Options & Structure Winner TLPH
BREAKDOWN (40th %ile IV) vs UNCLASSIFIED (100th %ile IV)
AQST NASDAQ
Aquestive Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.77
-3.45% 1D
Market Cap $448.7M
1M Return -0.13%
1Y Return -28.77%
Forward P/E N/M
Unified AI Score
59.4 / 100 HOLD
Tech 69.0 Fund 66.0 Flow 71.0 Mom 54.0
TLPH NASDAQ
Talphera, Inc. Common Stock
Pharmaceutical Preparations
$0.86
-4.98% 1D
Market Cap $53.7M
1M Return -20.29%
1Y Return -18.01%
Forward P/E 1.0x
Unified AI Score
37.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AQST -28.77% TLPH -18.01% Spread: +10.76 pp (TLPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AQST TTM Op. Margin: -114.1% TLPH TTM Op. Margin: -1474700.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AQST vs TLPH. Trailing 12-month operating profitability (AQST -114.1% vs TLPH -1474700.0%) and valuation multiples (AQST N/M vs TLPH 1.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AQST (6) vs TLPH (4)
Institutional Metric AQST TLPH Criterion Row Winner
Market Capitalization Scale $448.7M $53.7M Larger Scale AQST
Trailing P/E Ratio Valuation N/M 1.0x Lower Multiple TLPH
Forward P/E Ratio Valuation N/M 1.0x Lower Multiple TLPH
Revenue Growth (YoY) Growth -41.0% +0.0% Higher Growth TLPH
Operating Margin (TTM) Profitability -114.1% -1474700.0% Higher Margin AQST
Net Profit Margin Profitability -162.3% 0.0% Higher Margin TLPH
Return on Equity (ROE) Capital Efficiency 0.0% -143.4% Higher ROE AQST
52-Week Range Position Momentum 22% ($3โ€“$7) 20% ($1โ€“$2) Stronger Trend AQST
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 56% Vol 1.11ฮฒ ยท 58% Vol Lower Realized Risk AQST
Unified Institutional Score Composite Signal 59.4 / 100 (HOLD) 37.1 / 100 (SELL) Higher Composite AQST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AQST vs TLPH Buy Guide
AQST BREAKDOWN
57d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 40th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AQST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live TLPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AQST nor TLPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.